Nasdaq: LMRI · Listed Dec 11, 2025
Lumexa Imaging Holdings IPO
IPO price
$18.50
Lumexa Imaging Holdings (LMRI) priced its IPO at $18.50 a share and has traded on Nasdaq since Dec 11, 2025.
LMRI today$14.10-23.78%since IPO15-min delayed · as of 5:42:14 AM EST on Nov 19, 2026
See the LMRI quoteFirst trading day · Dec 11, 2025
- IPO price
- $18.50
- inside the range of $17 to $20
- First trade
- $18.65
- +0.81% from the IPO price
- First-day last trade
- $18.50
- +0.00% from the IPO price, regular session
- Raise
- $462.5M
- before the underwriters' option
These numbers are from the first trading day, Dec 11, 2025.
How LMRI did against the market
LMRI against the market, from its first trade at 12:55 ET to the last trade of the session.
- LMRI from its first trade
- -0.80%
- Against the market (QQQ)
- -1.2 pts
LMRI fell 0.8% from its first trade to the last trade of the session. That is 1.2 points worse than the market.
Same-day moves do not show that LMRI caused them. The market is QQQ, the Nasdaq-100 ETF.
The debut race
LMRI against other big listings, as the percent change from each stock's own IPO price.
The first 30 trading days. Each point is the last regular-session trade of a day.
The first trading day.
The first trading day.
The IPO scoreboard
LMRI against 6 other big listings: the return from each IPO's own price at the first trade, the close of day 1, day 5, and day 30.
| IPO | Raised | First trade | Day 1 close | Day 1 close, as a bar | Day 5 | Day 30 |
|---|---|---|---|---|---|---|
| Lumexa Imaging Holdings '25 | $462.5M | +0.81% | +0.00% | -7.62% | -24.11% | |
| Figma '25 | $1.22B | +157.58% | +252.42% | +173.64% | +69.64% | |
| Circle '25 | $1.05B | +122.58% | +168.45% | +278.18% | +622.98% | |
| Reddit '24 | $748M | +38.24% | +47.97% | +69.90% | +40.32% | |
| Arm '23 | $5.23B | +10.00% | +23.76% | +3.63% | -3.06% | |
| Klarna '25 | $1.37B | +30.00% | +16.14% | +13.73% | -7.33% | |
| CoreWeave '25 | $1.5B | -2.50% | +0.02% | +34.32% | +28.42% |
Day 1 is the last regular-session trade of the first day. Day 5 and day 30 are the last trade of the fifth and thirtieth trading day, counting the listing day as day 1. A cell fills in when that day has traded.
The offering
The Lumexa Imaging Holdings IPO offers 25M shares to raise $462.5M, before any underwriters' option.
- Expected price range
- $17 to $20
- IPO price
- $18.50
- Shares offered
- 25M
- Money raised
- $462.5M
- Listing date
- Dec 11, 2025
- Exchange
- Nasdaq
- Security
- Ordinary Shares
Money raised, against the largest IPOs
- Alibaba '14$21.77B
- Facebook '12$18.41B
- Rivian '21$11.93B
- Uber '19$8.1B
- Arm '23$5.23B
- Lumexa Imaging Holdings$462.5M
Where LMRI ranks
Lumexa Imaging Holdings's market cap against the largest US-listed companies.
Market cap, against the largest US-listed companies
- AAPL$5.12T
- MSFT$3.77T
- NVDA$3.65T
- GOOGL$3.47T
- AMZN$2.9T
- TSM$1.88T
- AVGO$1.69T
- META$1.58T
- TSLA$1.52T
- BRK.B$1.22T
- LMRI$1.35B
LMRI news
The latest news and headlines about Lumexa Imaging Holdings (LMRI).
- Why Lumexa (LMRI) Might be Well Poised for a SurgepositiveZacks Investment Research· Nov 17, 2026
- Lumexa Imaging Opens Three New Imaging Centers in NovemberpositiveGlobeNewswire Inc.· Nov 16, 2026
- Lumexa Imaging Expands Partnership with Advocate Health Through New Illinois Joint VenturepositiveGlobeNewswire Inc.· Nov 12, 2026
- Lumexa Imaging Announces Participation in Upcoming Investor ConferencesneutralGlobeNewswire Inc.· Aug 25, 2026
- Lumexa Imaging Appoints Kyle Lynch as Chief Growth OfficerpositiveGlobeNewswire Inc.· Apr 20, 2026
- Lumexa Imaging Holdings, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesnegativeGlobeNewswire Inc.· Mar 26, 2026
Filings and the company
What Lumexa Imaging Holdings has disclosed to the SEC, and the basic facts about the listing.
8-K filings
Material events that Lumexa Imaging Holdings discloses to the SEC on Form 8-K.
- Quarterly earningsNov 10, 2026
On November 10, 2026, Lumexa Imaging Holdings, Inc. (the "Company") issued a press release announcing the Company's financial results for the quarter ended September 30, 2026.
- Credit facilityJun 30, 2026
The Amended Credit Agreement provides for (i) a secured term loan facility of approximately $823 million (the 'Replacement Term Loan') and (ii) a secured revolving line of credit of $250 million (the 'Amended Revolving Credit Facility'). The Replacement Term Loan will bear interest at a rate per annum equal to, at the option of the Borrowers, SOFR plus 2.50% or the Prime Rate plus 1.50%, and will mature in December 2032. The Amended Revolving Credit Facility will bear interest at a rate per annum equal to, at the option of the Borrowers, SOFR plus 2.50% or the Prime Rate plus 1.50% (subject to reduction upon the achievement of certain senior secured net leverage ratios), and will mature in December 2030.
- Annual meeting resultsJun 12, 2026
At the Annual Meeting, all three director nominees were elected and the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 was ratified. Set forth below are the final voting results for the proposals submitted to a vote of the Company's stockholders at the Annual Meeting.
- Guidance issuance or updateApr 9, 2026
On April 8, 2026, Lumexa Imaging Holdings, Inc. (the "Company") held a meeting and site visit where the Company reiterated its previously disclosed full year 2026 guidance.
- Preliminary resultsMar 26, 2026
On March 26, 2026, Lumexa Imaging Holdings, Inc. (the "Company") issued a press release announcing certain preliminary financial information for the quarter and year ended December 31, 2025. The preliminary financial information set forth in the press release for the quarter and year ended December 31, 2025 reflects preliminary, unaudited estimates with respect to such results based solely on currently available information, which is subject to change.
About Lumexa Imaging Holdings
Lumexa Imaging Holdings Inc is a provider of diagnostic imaging services. The company offers a broad range of imaging modalities, including MRI, CT, PET, X-ray, ultrasound, and mammography. Its products and operations are managed and reported in two operating segments: Outpatient Imaging Centers (Outpatient) and Professional Services (Professional). The professional services segment generates revenue from interpreting imaging studies conducted by other parties, mainly hospital imaging departments. The majority of revenue is generated by the Outpatient segment, which performs imaging studies and provides radiologists' interpretations of those studies.
- Ticker
- LMRI
- Exchange
- Nasdaq
- Market
- stocks
- Type
- CS
- Currency
- USD
- Industry
- SERVICES-MEDICAL LABORATORIES
- Employees
- 4.34K
- Listed
- Dec 11, 2025
- Security
- Ordinary Shares
Frequently asked questions
What was the Lumexa Imaging Holdings IPO price?
$18.50 a share.
When did Lumexa Imaging Holdings go public?
Lumexa Imaging Holdings listed on Nasdaq on Dec 11, 2025 under the ticker LMRI.
How much did the Lumexa Imaging Holdings IPO raise?
$462.5M, before any underwriters' option.
How did Lumexa Imaging Holdings open on its first day?
LMRI first traded at $18.65, +0.81% from the IPO price of $18.50.
How did LMRI close on its first day?
Its last regular-session trade was $18.50, +0.00% from the IPO price of $18.50.
What was the LMRI first-day trading range?
$18.03 to $19.25 in the regular session.
How many LMRI shares traded on the first day?
6.52M shares in the regular session.
How many shares did Lumexa Imaging Holdings sell in its IPO?
25M shares.
How did LMRI do against the market on its first day?
LMRI fell 0.8% from its first trade to the last trade of the session. That is 1.2 points worse than the market (QQQ, the Nasdaq-100 ETF).
What exchange is LMRI listed on?
Lumexa Imaging Holdings lists on Nasdaq under the ticker LMRI.
Build with Massive
Get the LMRI data behind this page
| What the page shows | Endpoint |
|---|---|
| Offering terms and dates | /vX/reference/ipos |
| Price | /v3/snapshot |
| Chart, VWAP, and the market comparison | /v2/aggs/ticker/LMRI/range/5/minute |
| Market cap | /v3/reference/tickers/LMRI |
| News | /v2/reference/news |
| Filings | /vX/disclosures |
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.